Alice Casari

Dr. Alice Casari


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
ACAlice Casari
Alice Casari
JCJohanna Chester
Johanna Chester
GPGiovanni Pellacani
Giovanni Pellacani
Actinic keratosis represents the earliest manifestation of non-melanoma skin cancer. Because of their risk of progression to invasive squamous cell carcinoma, an earlier diagnosis and treatment are mandatory. Their diagnosis sometimes could represent a challenge even for expert dermatologists. Dermoscopy, confocal laser microscopy and optical coherence tomography could help clinicians in diagnosis.

3 July 2015
Verified
Journal Article
Closed access
SGStefania Guida
Stefania Guida
CLCaterina Longo
Caterina Longo
ACAlice Casari
Alice Casari
SCS Ciardo
S Ciardo
MMMarco Manfredini
Marco Manfredini
FFFrancesca Farnetani
Francesca Farnetani

23 March 2018 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
GPGiovanni Pellacani
Giovanni Pellacani
GGG. Gupta
G. Gupta
GMG. Micali
G. Micali
JMJ. Malvehy
J. Malvehy
ASA. J. Stratigos
A. J. Stratigos
TDT. Dirschka
T. Dirschka

16 July 2015
Verified
Journal Article
Closed access
CRC Reggiani
C Reggiani
MMMarco Manfredini
Marco Manfredini
VMVictor Desmond Mandel
Victor Desmond Mandel
FFFrancesca Farnetani
Francesca Farnetani
SCS Ciardo
S Ciardo
CLCaterina Longo
Caterina Longo

7 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
GPGiovanni Pellacani
Giovanni Pellacani
FFFrancesca Farnetani
Francesca Farnetani
JCJohanna Chester
Johanna Chester
Shaniko KaleciShaniko Kaleci
Shaniko Kaleci
SCSilvana Ciardo
Silvana Ciardo
MMMario Migaldi
Mario Migaldi
Background: The increasing global burden of melanoma demands efficient health services. Accurate early melanoma diagnosis improves prognosis. Objectives: To assess melanoma prevention strategies and a systematic diagnostic-therapeutical workflow (improved patient access and high-performance technology integration) and estimate cost savings. Methods: Retrospective analysis of epidemiological data of an entire province over a 10-year period of all excised lesions suspicious for melanoma (melanoma or benign), registered according to excision location: reference hospital (DP) or other (NDP). A systematic diagnostic-therapeutical workflow, including direct patient access, primary care physician education and high-performance technology (reflectance confocal microscopy (RCM)) integration, was implemented. Impact was assessed with the number of lesions needed to excise (NNE). Results: From 40,832 suspicious lesions excised, 7.5% (n = 3054) were melanoma. There was a 279% increase in the number of melanomas excised (n = 203 (2009) to n = 567 (2018)). Identification precision improved more than 100% (5.1% in 2009 to 12.0% in 2018). After RCM implementation, NNE decreased almost 3-fold at DP and by half at NDP. Overall NNE for DP was significantly lower (NNE = 8) than for NDP (NNE = 20), p < 0.001. Cost savings amounted to EUR 1,476,392.00. Conclusions: Melanoma prevention strategies combined with systematic diagnostic-therapeutical workflow reduced the ratio of nevi excised to identify each melanoma. Total costs may be reduced by as much as 37%.

14 January 2016 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ACAlice Casari
Alice Casari
Giuseppe ArgenzianoGiuseppe Argenziano
Giuseppe Argenziano
EMElvira Moscarella
Elvira Moscarella
ALAimilios Lallas
Aimilios Lallas
CLCaterina Longo
Caterina Longo